A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients

Anaesthesia

Volumn 52, Issue 9, 1997, Pages 833-841

  Smith, C E ^a   Van Miert, M M ^a   Parker, C J R ^a   Hunter, J M ^a  

^a School of Anaesthesia   (United Kingdom)

Author keywords

Metabolism; Neuromuscular relaxants; cisatracurium, atracurium; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ATRACURIUM; ATRACURIUM BESILATE; FENTANYL; LAUDANOSINE; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; THIOPENTAL;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYOGRAPHY; NEUROMUSCULAR BLOCKING; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0030885338     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.195-az0331.x     Document Type: Article

References (20)

1. Stenlake JB, Waigh RD, Dewar GH, et al. Biodegradable neuromuscular blocking agents. Part 6. Stereochemical studies on atracurium and related polyalkylene di-esters. European Journal of Medicinal Chemistry 1984; 19: 441-50.
2. Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ. Comparative pharmacology of cisatracurium (51W89): atracurium and five isomers in cats. Anesthesiology 1996; 85: 169-77.
3. Lien CA, Belmont MR, Abalos A, Abou-Donia M, Savarese JJ. Dose-response relations of 51W89: under nitrous-oxide-opioid-barbiturate anesthesia. Anesthesiology 1993; 79: A948.
4. Gibson FM, Mirakhur RK, Lavery GG, Clarke RSJ. Potency of atracurium: a comparison of single dose and cumulative dose techniques. Anesthesiology 1985; 62: 657-9.
5. Chapple DJ, Miller AA, Ward JB, Wheatley PL. Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. British Journal of Anaesthesia 1987; 59: 218-25.
6. Welch RM, Brown A, Ravitch J, Dahl R. The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasma. Clinical Pharmacology and Therapeutics 1995; 58: 132-42.
7. Beal SL, Sheiner LB. NONMEM User Guide. San Francisco: University of California, 1979.
8. Scott RPF, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG. Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. British Journal of Anaesthesia 1985; 57: 550-3.
9. Parker CJR, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. British Journal of Anaesthesia 1988; 61: 531-40.
10. Boyd AH, Eastwood NB, Parker CJR, Hunter JM. Pharmacodynamics of the 1R cis - 1′R cis isomer of atracurium (51W89) in health and chronic renal failure. British Journal of Anaesthesia 1995; 74: 400-4.
11. Bowman WC, Rodger IW, Houston J, Marshall RJ, McIndewar I. Structure: action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988; 69: 57-62.
12. Belmont MR, Lien CA, Quessy S, et al. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995; 82: 1139-45.
13. Tsui D, Graham GG, Torda TA. The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 1987; 67: 722-8.
14. Ward S, Boheimer N, Weatherley BC, Simmonds RJ, Dopson TA. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and patients in renal failure. British Journal of Anaesthesia 1987; 59: 697-706.
15. Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR. Importance of the organ - independent elimination of cisatracurium. Anesthesia and Analgesia 1996; 83: 1065-71.
16. Eastwood NB, Boyd AH, Parker CJR, Hunter JM. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. British Journal of Anaesthesia 1995; 75: 431-5.
17. Fisher DM, Claver Canfell P, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD. Elimination of atracurium in humans: contribution ot Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65: 6-12.
18. Parker CJR, Hunter JM. Pharmacokinetics of atracurium. British Journal of Anaesthesia 1991; 67: 129.
19. Weatherley BC, Williams SG, Neill EAM. Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered I. V. British Journal of Anaesthesia 1983; 55: 39S-45S.
20. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1996; 84: 300-8.